Supporting Indian MedTech Innovation: Panacea Medical
Indian-made Linear Accelerator by Panacea Medical gets US FDA approval
In 1999, G.V. Subrahmanyam, armed with a Master of Technology in Aeronautical Engineering from IIT Madras founded Panacea Medical Technologies in Whitefield, BLR, driven by a vision to Revolutionize Cancer Care. Sacrificing personal comforts, they crafted the Bhabhatron II and Siddharth II, earning ISO certifications and US FDA ((510(k) in 2010 for its Linear Accelerator Siddharth-II) clearance. (Click here!!)
➡ What is 510(k) FDA clearance: (Click FDA)
Welcome to all the supporters of Agenda+Health, here’s is what to expect:
Top-40🇮🇳 Healthcare Cos. ⬆️$113.2B in Mkt. Cap | Report
Future Roadmap with Sai Gopichand (IIT K) | Report
Autism Crisis in India: Parents & Providers perspective
AI Use-Case: The Chen Chemotherapy Model
Insta Viral Post: Mobile CT Scanner
Read time: 5 minutes
1/ India's Top 40 Healthcare Firms Surge $113.2B in Market Cap (2022-25)
Over 3 years, India's top 40 companies in HEALTHCARE collectively boosted their market capitalization by ₹9,61,985Cr ($113.2B), avg. ₹24,050Cr ($2.83B) per company.
Pharma Sector: Sun Pharma led ₹1,83,083Cr ($21.5B) gain,
Hospitals: Max Healthcare topped with ₹75,677Cr ($8.9B).
Medical Devices: Poly Medicure shone with a ₹13,780Cr ($1.62B) increase.
Diagnostics: Dr. Lal PathLabs stood alone, adding ₹1,535Cr ($0.18 billion).
Top-40 Healthcare Companies in India in terms of Market Cap. Growth over last 3years
To know about the reasons of this growth, whether it is due to Covid, Regulatory Support, Exports, Patent Expiry, Insurance Penetration, US FDA approvals, M&A or R&D.
➡Download the attached Report prepared by Agenda+Health below:
2/ Future Roadmap of Agenda+Health with Sai Gopichand (IIT K)
Sai Gopichand, an Aerospace Engineer from IIT Kanpur has formally joined Agenda+Health. With >12years of experience, he’ll handle the Healthtech, AI & Medical Engineering aspects.
Sai Gopichand | IIT K | Aerospace Engg.
With a limited professional healthcare experience but deep personal insight from 3years of navigating
-injuries, -surgeries, and -recovery,
he engaged with Doctors & Healthcare Professionals to understand their perspectives and challenges.
He plans to map the HEALTHCARE and SELF-CARE ecosystem, placing the INDIVIDUAL at its core, identifying Business Opportunities, Innovations, and Services at each node.
3/ Understanding the Autism Crisis in India from all Stakeholders: Parents and Providers
We've surpassed Japan in GDP but does it signify growth? 1 in 50 kids're facing Developmental Delays today. Given🇮🇳is birthing 2.5Cr kids/yr, by 2047, >1Cr children will be on the spectrum. Do we have Developmental Therapists? (Read more on LinkedIn)
India is lagging way behind as far as Developmental Therapists are concerned.
PARENT Pain-point 1: Lack of Tracking
Lack of Progress Tracking
PARENT Pain-point 2: Spread-out Information, No Service Standardisation
Silo’ed Information
PARENT Pain-point 3: Unaware Schools
Schools are NOT equipped
PARENT Pain-point 4: Complacent Special Needs Schools
Complacent Schools
DOCTORS Pain-points: explained by Dr. Sreetama Chowdhury
New Branch | Inter-Disciplinary Field | Lack of Early Diagnosis
4/ AI is helping in providing Continuous Cancer Care post Chemotherapy ⏳
USE-CASE: - Predicting when a patient needs to be hospitalised post Chemotherapy
Often, chemotherapy patients find themselves struggling with side effects such as general pain, fever, diarrhea, fatigue, and vomiting; these are red flags that frequently lead to hospitalizations. According to a study by the National Institutes of Health, “of 18,486 patients who received chemotherapy for metastatic cancer, 92% were hospitalized at least once for any reason, including 51% hospitalized for a likely toxicity.”
An AI driven tool used by Mercy and called the Chen Chemotherapy model is helping patients steer clear of complications after chemotherapy
The program works by creating a risk score for non-leukemia chemotherapy patients over 18 years old. As the program learns, it’s able to predict how likely it is that a patient who is experiencing symptoms will be hospitalized within 30 days after their chemotherapy treatment.
Once patients are opted into the smart texting platform, they will receive a text each day for seven days, minus weekends and holidays, to monitor their symptoms. When a patient selects a symptom, they rate it and, based on their answers, the information may be sent to their provider.
5/ Mobile CT Scanner by Siemens: SOMATOM
An innovation in achieving Point-of-Care Diagnostics with more accessible, bedside imaging delivery.
